Alteplase recombinant Tissue plasminogen activator

A patient with an MI receives an alteplase recombinant Tissue plasminogen activator. The nurse should report which of the following to the physician as being an untoward effect of medication. a. Epistaxis b. Absent pedal pulses c. ST. segment elevation on the ECG d. Vomiting